VHCP Management’s Heron Therapeutics HRTX Stock Holding History

VHCP Management’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$14.4M	Hold	1,095,734	–	–	15.43%	2
2016 Q3	$18.9M	Hold	1,095,734	–	–	18.57%	2
2016 Q2	$19.8M	Hold	1,095,734	–	–	20.5%	2
2016 Q1	$20.8M	Hold	1,095,734	–	–	18.07%	2
2015 Q4	$29.3M	Hold	1,095,734	–	–	17.68%	2
2015 Q3	$26.7M	Hold	1,095,734	–	–	6.85%	4
2015 Q2	$34.1M	Hold	1,095,734	–	–	9.63%	4
2015 Q1	$15.9M	Hold	1,095,734	–	–	3.67%	9
2014 Q4	$11M	Hold	1,095,734	–	–	3.03%	10
2014 Q3	$9.13M	Hold	1,095,734	–	–	4.1%	9
2014 Q2	$13.5M	Hold	1,095,734	–	–	7.21%	5
2014 Q1	$15.2M	Sell	1,095,734 -1	-0%	-$13	7.92%	6
2013 Q4	$9.86M	Buy	1,095,735 +642,350	+142%	+$5.78M	5.31%	7
2013 Q3	$3.04M	Buy	+453,385	New	+$3.04M	1.68%	15

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

VHCP Management's HRTX Position: Q4 2016 in Review

VHCP Management held its Heron Therapeutics (HRTX) position steady in Q4 2016 at 1,095,734 shares worth $14.4M. The position accounts for 15.43% of the portfolio, ranked #2.

VHCP Management first reported a position in HRTX in Q3 2013 and has held it in 14 quarters since. The position peaked at $34.1M in Q2 2015. 99 funds tracked by Wall St. Rank hold HRTX as of Q4 2016.

VHCP Management held 1,095,734 shares of Heron Therapeutics worth $14.4M as of Q4 2016.
VHCP Management left its Heron Therapeutics share count unchanged in Q4 2016.
Heron Therapeutics made up 15.43% of VHCP Management's portfolio in Q4 2016, its #2 holding.
VHCP Management first reported a position in Heron Therapeutics in Q3 2013 and has held it in 14 quarters since.
VHCP Management's Heron Therapeutics position peaked at $34.1M in Q2 2015.
99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.